AVADEL
LIVE

Serial Number

86922879

Owner

Flamel Ireland Limited

Attorney

Norm J. Rich

First Use Date

Jan 3, 2017

Filing Date

Feb 29, 2016

Add to watchlist:

No watchlists yet
View on USPTO

AVADEL Trademark

Serial Number: 86922879 • Registration: 5242378

AVADEL is a trademark filed by Flamel Ireland Limited on February 29, 2016. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Flamel Ireland Limited

Ten Earlsfort Terrace
Dublin 2 D02T380 , IE

Entity Type: 99

Trademark Details

Filing Date

February 29, 2016

Registration Date

July 11, 2017

First Use Anywhere

January 3, 2017

First Use in Commerce

January 3, 2017

Published for Opposition

September 27, 2016

Goods & Services

Provision of pharmaceutical advice; provision of pharmaceutical information, namely, the diagnostic, prophylactic and therapeutic properties of pharmaceuticals and instructional information for use of the pharmaceutical products

Pharmaceutical preparations and medications for use in the treatment of [ hypotension in the setting of anesthesia; pharmaceutical preparations and medications for treating pain management, respiratory diseases and disorders, allergic disorders, gastrointestinal disorders, ] sleep disorders [, dermatological conditions, pulmonary diseases, obstetrics and gynecology; pharmaceutical products, namely, pharmaceutical agents and preparations for the treatment of autoimmune diseases, bacterial infections, chronic anemia, hypotension, disorders of the musculo-skeletal system, for maintaining blood pressure, for the reversal of the effects of anesthesia, for the reversal of the effects of non-depolarizing neuromuscular blocking agents ] ; chemical preparations for medical [ and veterinary ] purposes for injection or oral administration, namely, a drug delivery system in the form of coatings, tablets that provide continuous and controlled release of active ingredients in a wide variety of therapeutic agents to human patients; drug delivery agents in the form of encapsulated pharmaceutical preparations for the prolonged and controlled release of active ingredients, for the treatment of a wide variety of diseases and disorders [ ; injectable medication used to reverse anesthesia; medication used to maintain blood pressure ]

Provision of pharmaceutical information in the fields of pharmaceutical research and chemical and biochemical analysis for research purposes

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 20, 2026 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Apr 20, 2026 ECDR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
Apr 20, 2026 EWOR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 20, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 20, 2026 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Apr 20, 2026 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Apr 20, 2026 COAR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 17, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 17, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 17, 2025 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 17, 2025 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jan 17, 2025 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 17, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 17, 2025 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 15, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Jun 15, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 15, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 15, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 15, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Jun 15, 2023 COAR
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Feb 2, 2023 NA85
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Feb 2, 2023 C15A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 31, 2023 APRE
TEAS SECTION 8 & 15 RECEIVED
Jul 13, 2022 E815
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 11, 2022 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 11, 2017 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jun 6, 2017 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jun 5, 2017 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 4, 2017 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 2, 2017 AITU
USE AMENDMENT FILED
May 9, 2017 IUAF
TEAS STATEMENT OF USE RECEIVED
May 9, 2017 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 22, 2016 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 27, 2016 NPUB
PUBLISHED FOR OPPOSITION
Sep 27, 2016 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 7, 2016 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 18, 2016 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 16, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 16, 2016 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 16, 2016 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Aug 15, 2016 GNFN
FINAL REFUSAL E-MAILED
Aug 15, 2016 GNFR
FINAL REFUSAL WRITTEN
Aug 15, 2016 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 28, 2016 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 27, 2016 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 27, 2016 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 13, 2016 GNRN
NON-FINAL ACTION E-MAILED
Jun 13, 2016 GNRT
NON-FINAL ACTION WRITTEN
Jun 13, 2016 CNRT
ASSIGNED TO EXAMINER
Jun 13, 2016 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 3, 2016 NWOS
NEW APPLICATION ENTERED
Mar 3, 2016 NWAP